Daré Bioscience, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference

Author's Avatar
Aug 30, 2018
Article's Main Image

Update on recent discussions with the FDA on the Topical 5% Sildenafil Citrate Cream for Female Sexual Arousal Disorder, and on other protofolio programs